{"changes":[],"country":"US","description":"Allyx Therapeutics develops ALX-001, a candidate designed to preserve synapses in Alzheimer's and Parkinson's disease. It targets patients suffering progressive neurodegenerative disease. Differentiator: synaptic protection rather than the typical amyloid- or tau-targeting disease modification.","domain":"allyxthera.com","employees":null,"founded":2019,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":41.308214,"lng":-72.925052,"location":"NEW HAVEN, Connecticut","name":"ALLYX THERAPEUTICS INC","rounds":[{"amountQuarantined":false,"amountUsd":3347703,"currency":"USD","date":"2024-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"allyxthera-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"allyxthera.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://allyxthera.com"},{"fact":"description","publisher":"allyxthera.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://allyxthera.com"}],"stage":null,"techStack":["Nginx","The SEO Framework","reCAPTCHA","Google Analytics","Google Tag Manager","FitVids.JS 4.24.3","jQuery Migrate 3.4.1","Divi","DoubleClick Floodlight","WordPress","PHP","MySQL"],"totalRaisedUsd":23000000,"updatedAt":"2026-05-02"}